Carisma Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 27, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $53,000,000
Company Info
- Company Description
- Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
- Market
- Therapeutics for solid tumor patients
- Location
- Philadelphia, PA, USA
- Coinvestors
- AbbVie Biotech Ventures, Agent Capital, Grazia Equity, HealthCap, IP Group, MRL Ventures Fund, Penn Medicine, TPG Biotech